Home/ Supplements/ Omega 3/ Fresh Catch Ultra EPA-DHA Fish Oil Orang...

Fresh Catch Ultra EPA-DHA Fish Oil Orange Flavor

product on market Softgel Capsule Barlean's Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Fresh Catch Ultra EPA-DHA Fish Oil Orange Flavor
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
30
Servings
Fat/Fatty Acid
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
2 Gram(s) (3% DV)
Cholesterol
5 mg (2% DV)

Other Ingredients

Fish Oil Softgel natural Citrus flavor Antioxidant Blend
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: 2 softgels daily with a meal.

Warnings & Precautions

Store in a cool, dry place out of reach of children.

Formulation Notes

Barlean's Fresh Catch Ultra EPA-DHA Fish Oil

1,300 mg of Omega-3s in just two softgels

From wild caught fish

Free of mercury and other heavy metals Non-GMO, Gluten Free, no PCBs

Pharmaceutical Grade Ultra Purified

1,300 mg Omega-3

Additional Information

From our family to yours Barbara Barlean David Barlean Bruce Barlean

Learn more about a pathway to a better life: barleans.com

FreshTech Patented Softgel Technology

Barlean's estd 1989

Keep bottle tightly closed. Store in a cool, dry place out of reach of children.

Product of U.S.A.

Metadata

Product Details

UPC / SKU7 05875 61006 3
DSLD Entry Date2020-03-24
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID215877
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.